Cancer Research Science Product News | Technology Networks

We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Cancer Research

Cancer Research

Featured Products

Incucyte® SX5 Live-Cell Imaging System

Incucyte® SX5 Live-Cell Imaging and Analysis System

Sartoclear Dynamics® Lab One-step Cell Culture Harvesting content piece image

Sartoclear Dynamics® Lab One-step Cell Culture Harvesting

Gloved hands holding a vial with a depiction of DNA strands inside and on the background.

Oligonucleotide Solutions from Target ID and Validation to IND

LipidLaunch™: Lipid Nanoparticle Research Tools for RNA Therapies

Product News

Row of laboratory centrifuges with digital displays used for sample separation workflows.

Thermo Fisher Scientific Introduces General Purpose Centrifuges With Next-Generation Natural Refrigerant Cooling

Thermo Fisher launches X and S Series centrifuges with high performance, versatile design and low-GWP cooling technology.

Scientist analyzing laboratory data with AI-driven software on advanced research equipment.

Pistoia Alliance Research Finds 1 in 4 Life Sciences Professionals Do Not Know What Data Their AI Models Use

Pistoia Alliance poll reveals many life science AI systems rely on incomplete or unclear scientific data sources.

Illustration of cancer cells highlighting targeted treatment advances enabled by the FDA-approved Oncomine Dx Test for HER2-mutated NSCLC.

Thermo Fisher Scientific’s Oncomine Dx Target Test Receives FDA Approval as a Companion Diagnostic for NSCLC Patients

FDA approves Thermo Fisher’s Oncomine Dx Target Test as a CDx to identify NSCLC patients with HER2 mutations eligible for HYRNUO therapy.

Pipette dispensing medium into a culture dish to illustrate Detachin’s gentle, rapid release of delicate adherent cells.

Gentle and Rapid Detachment of Even Delicate Adherent Cells

Detachin^TM enables gentle, rapid detachment of diverse adherent cells while preserving viability, phenotype and downstream assay performance.

Illustration of immune cells targeting a tumor, representing advances in personalized T-cell therapies for esophageal cancer under the EU’s TRANSCAN-3 project.

EU-Funded TRANSCAN-3 Project Marks Milestones in Personalized Immunotherapy for Esophageal Cancer

TRANSCAN-3 advances personalized T-cell therapies for esophageal cancer with progress in neoantigen discovery and T-cell isolation.

Laboratory scientists working with clinical samples, symbolizing automated, high-sensitivity M-protein testing enabled by Thermo Fisher’s EXENT System.

Thermo Fisher Scientific Receives 510(k) Clearance in US for EXENT System To Aid Diagnosis of Multiple Myeloma

Thermo Fisher’s EXENT System receives FDA clearance, delivering automated, sensitive M-protein detection to support earlier multiple myeloma diagnosis.

3D illustration of immune-like cells with surface markers, representing somatic cancer mutations and diagnostic reference standards.

Revvity Collaborates With MDIC and NIST To Launch Somatic Cancer Reference Standards

Revvity, MDIC and NIST introduce new somatic cancer reference standards to help labs monitor accuracy and reliability of NGS-based diagnostics.

3D illustration of cells with highlighted centers, representing high-plex mapping of cell-cell communication in tissue samples.

Moleculent Launches Early Access Program To Decode Cell-Cell Communication at Scale

Moleculent’s Techstart program gives researchers early access to its high-plex platform for mapping direct cell-cell interactions in FFPE tissues.

OGT SureSeq Myeloid MRD Plus NGS Panel kit with storage box and reagent tube used for ultra-sensitive MRD detection in AML.

OGT Expands MRD Detection Capabilities With New SureSeq Myeloid MRD Plus NGS Panel

OGT launches the SureSeq Myeloid MRD Plus Panel, enabling ultra-sensitive MRD detection in AML with variant calls down to 0.01%.

Watchmaker Genomics TAPS+ packaging with tagline 'The Power of Positive,' for next-gen methylation oncology research.

Watchmaker Genomics Launches TAPS+, Expanding Multimodal Capabilities in Oncology Ahead of AMP 2025

Watchmaker Genomics launches TAPS+, enabling simultaneous detection of methylation and genetic variants for cancer research.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter